Tuberin activators include a variety of compounds that indirectly enhance the functional activity of tuberin (TSC2), a critical regulator in the mTOR signaling pathway. The primary mechanism through which these activators function involves the modulation of upstream signaling molecules that influence TSC2's activity. A significant number of these compounds, including 1,1-Dimethylbiguanide, AICAR, Resveratrol, Quercetin, SRT1720, Salicylate, and Berberine, activate AMPK (AMP-activated protein kinase). Activated AMPK can phosphorylate and activate TSC2, thereby enhancing its tumor suppressor function and its inhibitory effect on the mTORC1 pathway. This activation is crucial for controlling cellular processes like growth, proliferation, and survival, particularly under conditions of cellular stress or nutrient deprivation.
In addition to AMPK activators, other tuberin activators work by inhibiting mTOR directly or modulating related pathways. Compounds like Rapamycin inhibit mTOR or PI3K, leading to compensatory mechanisms that result in the activation of TSC2. This indirect activation through feedback inhibition within the mTOR pathway underscores the complex regulatory mechanisms controlling cell growth and proliferation. By targeting various components of the mTOR signaling pathway, these activators provide insights into the modulation of key regulatory proteins like tuberin, highlighting strategies for diseases associated with dysregulated mTOR signaling, such as tuberous sclerosis and certain types of cancer.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTORC1, part of the mTOR pathway. This inhibition indirectly influences tuberin (TSC2), a negative regulator of mTORC1. While Rapamycin doesn't directly activate TSC2, its suppression of mTORC1 can lead to feedback mechanisms enhancing TSC2's activity. Thus, Rapamycin has a complex relationship with TSC2, acting as an indirect activator through the suppression of mTORC1, despite potential direct inhibitory effects on TSC2 via AKT phosphorylation. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
1,1-Dimethylbiguanide, Hydrochloride activates AMPK, which can phosphorylate and activate TSC2, enhancing its role in inhibiting the mTOR pathway. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMPK, which in turn can enhance TSC2 activity, leading to decreased mTORC1 signaling. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol has been shown to activate AMPK. Activated AMPK can phosphorylate TSC2, enhancing its tumor suppressor function. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin can activate AMPK. Through AMPK activation, it might enhance TSC2 activity and its inhibition of mTORC1. | ||||||
SRT1720 | 1001645-58-4 | sc-364624 sc-364624A | 5 mg 10 mg | $197.00 $364.00 | 13 | |
SRT1720 is an activator of SIRT1, which can influence AMPK and potentially lead to enhanced TSC2 activity. | ||||||
Salicylic acid | 69-72-7 | sc-203374 sc-203374A sc-203374B | 100 g 500 g 1 kg | $47.00 $94.00 $119.00 | 3 | |
Salicylate activates AMPK. Through this activation, it might indirectly enhance TSC2 function in the mTOR pathway. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Berberine activates AMPK, which may subsequently enhance TSC2 activity, leading to reduced mTORC1 signaling. | ||||||